Latest Breaking News On - பென் நிலை துணிகர - Page 1 : comparemela.com

Penn State startup aims to improve treatment of hydrocephalus Normal pressure hydrocephalus is a disease resulting from too much cerebrospinal fluid around the brain. NPH symptoms are often confused with Alzheimer’s disease but in many cases are reversible with the placement of a shunt. The HydroFix shunt developed by Penn State researchers is designed to mitigate the risks associated with the current shunts on the market and provide a durable treatment solution for NPH patients.Image: Penn State Penn State startup aims to improve treatment of hydrocephalus May 28, 2021 UNIVERSITY PARK, Pa.  Normal pressure hydrocephalus (NPH) is a disease resulting from too much cerebrospinal fluid (CSF) around the brain and affects roughly 750,000 Americans, typically those over 65 years old. Symptoms are often confused with Alzheimer’s disease, but in many cases they are reversible with the placement of a shunt.  

United statesKevin harterJim pietropaoloRandy haluckHarl tolbertElias rizkBarry fellDustin ritterNational science foundation innovation corpsOffice of technology managementPenn state research foundationPenn state college of medicineInnovation at penn state college of medicineStartup leadership networkSurgical innovation groupOffice of entrepreneurship